Johnson & Johnson Sees $2.08M Bullish Options Surge as Stock Hovers Near 52-Week Highs

By TrendSpider Editor

Johnson & Johnson is drawing serious attention in the options market, with a dominant bullish call contract driving over $2.1 million in total unusual options premium on Tuesday. JNJ shares are trading at $259.59, down 0.82% on the session, but remain well positioned within their 52-week range of $1

Johnson & Johnson Sees $2.08M Bullish Options Surge as Stock Hovers Near 52-Week Highs

Johnson & Johnson is drawing serious attention in the options market, with a dominant bullish call contract driving over $2.1 million in total unusual options premium on Tuesday. JNJ shares are trading at $259.59, down 0.82% on the session, but remain well positioned within their 52-week range of $171.81 to $274.89, sitting closer to the upper end of that range. Two unusual contracts were flagged today, with the headline trade being a massive call sweep that signals at least some institutional players are positioning for a meaningful move higher over the next several months.

Key Drivers of the JNJ Stock Move

• Main Catalyst: Two unusual options contracts were detected on JNJ today, generating a combined $2,115,145 in total premium. The dominant trade was a CALL at the $280 strike expiring January 15, 2027, with a volume of 2,190 contracts and open interest at 91% of that volume, representing $2,080,500 in premium. A smaller PUT at the $260 strike expiring December 17, 2027, carried a size of 13 contracts at 260% of open interest, generating $34,645 in premium.
• Bull Case: The $280 call position, worth $2,080,500 in premium, is a significant out-of-the-money bet that JNJ will trade above $280 by January 15, 2027, roughly five months away. Given that the 52-week high sits at $274.89, this trade implies a breakout above prior highs. The sheer size of 2,190 contracts relative to existing open interest at 91% suggests this is likely a fresh institutional position, not a retail accumulation play.
• Bear Case: The in-the-money PUT at the $260 strike expiring December 17, 2027, while small in premium at $34,645, is notable because its open interest ratio stands at 260%, meaning the day's volume significantly exceeded existing open interest. This suggests new bearish positioning. With JNJ currently at $259.59, the $260 put is already in the money, adding a layer of near-term caution to the otherwise bullish options picture.

The forward setup for JNJ is an interesting tug-of-war between a large institutional call position targeting a breakout above all-time highs and a smaller but statistically notable put trade already in the money. The stock's current price of $259.59 puts it just below the $260 put strike, meaning bears have a slight edge in the short term if the stock cannot reclaim that level. Bulls, however, are swinging for a move above $280 by January, a target that would require JNJ to clear its 52-week high of $274.89 and establish new ground. With total unusual premium concentrated heavily on the call side at roughly 98% of the $2.1 million total, the weight of smart money activity today leans constructive on JNJ's intermediate-term trajectory.

JNJ Unusual Options Activity

• Contract 1: CALL | Strike: $280 | Expiry: January 15, 2027 | Volume: 2,190 | Open Interest: 91% | OTM | Premium: $2,080,500
• Contract 2: PUT | Strike: $260 | Expiry: December 17, 2027 | Volume: 13 | Open Interest: 260% | ITM | Premium: $34,645

The January 2027 call dominates the unusual flow with 2,190 contracts and $2,080,500 in premium, making it the clear headline trade. The open interest ratio of 91% on the call suggests this position is building on an already sizable base. In contrast, the December 2027 put's 260% open interest ratio on just 13 contracts indicates a small but statistically unusual bearish position that may reflect a hedge rather than an outright directional bet.

JNJ Seasonality

August has historically been a mixed month for large-cap healthcare names like JNJ, with the sector often experiencing subdued activity ahead of fall clinical conference season. The January 2027 expiry on the dominant call contract captures the period that typically includes JNJ's fourth-quarter earnings report, which may be part of the event-driven thesis behind this trade.

JNJ Relative Performance

JNJ's current price of $259.59 reflects a 0.82% decline on the session, a modest pullback for a stock trading roughly $85 above its 52-week low of $171.81. With the 52-week high at $274.89, JNJ is trading within approximately 5.9% of its annual peak, suggesting relative strength compared to where it was at its lowest point over the past year. The stock's proximity to its 52-week high, even on a down day, reinforces the bullish options thesis embedded in the $280 call position.